Fortis Health. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,007.00
857.00
813.00
987.00
43.00
239.00
Adjustment
636.00
444.00
307.00
99.00
407.00
418.00
Changes In working Capital
-110.00
19.00
-24.00
-10.00
-12.00
-146.00
Cash Flow after changes in Working Capital
1,533.00
1,321.00
1,096.00
1,076.00
438.00
511.00
Cash Flow from Operating Activities
1,423.00
1,100.00
822.00
865.00
485.00
171.00
Cash Flow from Investing Activities
-779.00
-889.00
-372.00
-500.00
-130.00
63.00
Cash Flow from Financing Activities
-713.00
-86.00
-471.00
-517.00
-142.00
-861.00
Net Cash Inflow / Outflow
-69.00
124.00
-21.00
-152.00
212.00
-626.00
Opening Cash & Cash Equivalents
169.00
45.00
66.00
219.00
7.00
633.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
99.00
169.00
45.00
66.00
219.00
7.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Fortis Health.
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
1007.05
1505.1
-498.00
-33.09%
Adjustment
636.91
1721.2
-1,085.00
-63.00%
Changes In working Capital
-110.36
-603.9
493.00
81.73%
Cash Flow after changes in Working Capital
1533.59
2622.4
-1,089.00
-41.52%
Cash Flow from Operating Activities
1423.93
2136.4
-713.00
-33.35%
Cash Flow from Investing Activities
-779.84
-3380.6
2,601.00
76.93%
Cash Flow from Financing Activities
-713.85
1316.8
-2,029.00
-154.21%
Net Cash Inflow / Outflow
-69.76
72.6
-141.00
-196.09%
Opening Cash & Cash Equivalents
169.66
505.5
-336.00
-66.44%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
99.91
578.1
-479.00
-82.72%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 29.44% vs 33.79% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
1,423.93
1,100.10
29.44%






